testosterone injury lawyer

May 12, 2016

Study: Testosterone Replacement Therapy May Benefit Diabetic Men

Over the past decade, testosterone replacement therapy (TRT) has become a one of the most prescribed medications available, with hundreds of thousands undergoing the therapy each year. However, it should be noted that the vast majority of these patients are not taking the drug because they have the medical condition for which the U.S. Food and Drug Administration (FDA) approved the drug to treat.

When hormone replacement therapy drugs came on the market in the 1970s, it was labeled for use with a medical condition know as hypogonadism. These patients who suffered from hypogonadism had very low testosterone count and were typically diagnosed at a fairly young age. This is still the only medical condition that FDA approved the hormone therapy to treat. Continue reading

February 18, 2016

Pros and Cons of Testosterone Replacement Therapy (TRT)

by Jeffrey S. Glassman

There has been a great deal of debate about whether there is any medical benefit to taking testosterone replacement therapy (TRT). It should first be noted, we are talking about men who do not suffer from hypogonadism. Hypogonadism is a rare medical condition characterized by an extremely low testosterone level, especially during a time when the patient is still developing.

This condition is the reason testosterone therapy was created, and it is currently the only condition for which the United States Food and Drug Administration (FDA) approved TRT in the 1970s, and this has not changed. This is not to say that the many so-called T clinics around the country are prescribing testosterone replacement therapy illegally, but they are administering for an off-label use. Continue reading

January 25, 2016

Opioids May Be Linked to Lower Testosterone Levels

by Jeffrey S. Glassman

While it is getting impossible to watch a sports even on television without seeing an add for testosterone replacement therapy, doctors do not know that much about the so-called medical condition of low testosterone, new research is suffering that a patient is significantly more likely to experience lower testosterone levels when he is taking prescription opioid based pain medications like Percocet according to a recent article from Renal & Urology News.

First, it should be noted that researchers at Janssen Pharmaceuticals, which is a wholly owned subsidiary of giant drug manufacturer Johnson & Johnson, conducted this study. As we have seen too many times in the past, some of these major drug manufacturers have been more interested in making huge profits than they are in patient safety. It should, therefore, come as no surprise that failure to warn patients and doctors of a known danger and defective design of a drug have been the basis for thousands of dangerous drug lawsuits. Continue reading

October 10, 2015

Risks Involved in Testosterone Replacement Therapy

by Jeffrey S. Glassman

A recent article in the Herald-Review features a question and answer series between readers and a doctor who works with the media outlet. The main question asked in the latest issue involved the risks of testosterone replacement therapy (TRT). The reader who asks the question is a 62-year-old man who is currently receiving testosterone replacement injections on a weekly basis.

The man said he has blood tests performed more than twice a year and, each time, all of his blood work comes back normal. He said he has no noticeable side effects from the testosterone hormone injections, but his temper is much shorter than it has ever been before. He said his doctor told him he is on Arimidex to lower his estrogen levels, and that testosterone injections are not harmful to him in terms of dangerous side effects. This reader said he wants another opinion, because he is fearful that TRT may cause a stroke. Continue reading

October 7, 2015

Endocrinologists’ Association Responds to FDA Testosterone Theory

by Jeffrey S. Glassman

According to a recent news article from Medscape Multispecialty, the American Associate of Clinical Endocrinologists (AACE) has just issued a position statement on the use testosterone replacement therapy. This is in direct response to United States Food and Drug Administration (FDA) warning about how testosterone replacement therapy can have serious cardiovascular effects on patients.

AACE is agreement with FDA that more safety and efficacy trials are needed with respect to hormone replacement therapy. The association also has concerns with how studies in the past have been performed. Specifically, they are concerned that studies have not been sufficiently randomized and controlled to accurately determine causality between testosterone replacement therapy use and increased risks for cardiovascular disease. Continue reading

July 31, 2015

Testosterone Injections Shown Not to Help with Sexual Dysfunction

by Jeffrey S. Glassman

For years, testosterone replacement therapy has been marketed as the ultimate treatment for aging men who are experiencing weight gain, loss of muscle tone, fatigue, mild depression, erectile dysfunction (ED), and a reduced libido. In other words, they are marketing so-called Low-T treatments for men who are getting older. The problem is that these claims are not based on any scientific studies, and many in the medical community do not believe there is much benefit for patients who take the drug.

According to a recent news article from the Huffington Post, a four-month study found testosterone replacement therapy does not help with the alleged sexual side effects of having a lower than average testosterone level. Continue reading

July 22, 2015

Low T Study: Testosterone Replacement Therapy Doesn’t Fix Ejaculation Problems

by Jeffrey S. Glassman

The number of men taking hormone replacement therapy has gone up by over 400 percent in the past 10 years. The main reason for this is not because more men have developed the relatively rare medical condition known as hypogonadism (the only FDA approved reason for testosterone hormone), but because the drug companies have spent a lot of money marketing the hormone regimen for men who are experiencing the normal signs of male aging.

These signs of normal male aging include loss of libido, weight gain, tiredness, muscle fatigue and mild depression, among others. The makers of testosterone replacement therapy drugs and the owners and operators so called “T clinics” are using testosterone for the off-label use of allegedly treating these “symptoms” of the normal male aging process. Continue reading

June 21, 2015

Study: High Testosterone Linked to Diabetes, Prostate Enlargement

by Jeffrey S. Glassman

Hoards of testosterone products have been heavily marketed to men in recent years, promising increased vigor, stamina and health. Drug manufacturers marketed these to males who reportedly suffered from “Low-T,” or an inadequate level of the hormone.

We are now learning the reality is not only are these drugs ineffective for that purpose, they may actually cause a substantial amount of harm.

A new study conducted by researchers at the University of California Santa Barbara and published in the Journals of Gerontology: Medical Sciences indicates these drugs are linked to a markedly increased risk of diabetes and prostate enlargement.